By Kelly Cloonan
Windtree Therapeutics plans to create a policy that will allow it to accept cryptocurrency payments and hold cryptocurrency as an asset.
Chief Executive Jed Latkin said Tuesday the policy is part of the biotechnology company's new strategy to generate revenue.
Windtree is in discussions with several bitcoin- and other cryptocurrency-focused groups that are interested in furthering a treasury strategy with the company, Latkin said.
The company expects the policy will be completed in the near term, he said.
The stock declined 8% to 73 cents in after-hours trading Tuesday.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
June 03, 2025 17:09 ET (21:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
The articles, information, and content displayed on this webpage may
include materials prepared and provided by third parties. Such
third-party content is offered for informational purposes only and
is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the
accuracy, completeness, timeliness, or reliability of any third-party
content displayed on this site. The views and opinions expressed in
third-party content are those of the respective authors and do not
necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays
in this content, nor for any actions taken in reliance thereon.
Users are advised to exercise their own judgment and seek independent
financial advice before making any decisions based on such content.
The third-party providers of this content are not affiliated with
Morningstar, and their inclusion on this site does not imply any
form of partnership, agency, or endorsement.